Atlas Trials

A Study to Evaluate Diagnostic Sensitivity and Specificity of iStatis HBsAg Test at the Point-Of-Care Sites

Clinical trial NCT06368466 · COMPLETED

Trial details

NCT number
NCT06368466
Sponsor
bioLytical Laboratories
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Hepatitis BHepatitis B Infection
Start date
2024-04-30
Primary completion
2024-07-05
Enrollment
175

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.